Skip to content
← Holders

Sarissa Capital Management LP

What Sarissa Capital Management LP reported holding on Form 13F for the quarter ended Sep 30, 2026.

CIK 1577524 · Filed Nov 16, 2026

Positions
10
Reported value
$153.2M
Opened
0
Closed
0
Other managers included
0

Values are as the managers reported them, in dollars.Open the Form 13F on SEC EDGAR

Quarters on file

  1. Sep 30, 2025$180.4M
    8 positions
  2. Dec 31, 2025$222.9M
    9 positions
  3. Mar 31, 2026$157.6M
    9 positions
  4. Jun 30, 2026$177.9M
    10 positions
  5. Sep 30, 2026$153.2M
    10 positions
SecuritySharesChangeValueOf portfolio
INVAInnoviva, Inc.
1.9M±0%$40.1M26.2%
IRWDIronwood Pharmaceuticals Inc
9.2M±0%$36.5M23.8%
AMRNAmarin Corp Plcuk
1.3M−23.1%$16.7M10.9%
LNTHLantheus Holdings, Inc.
166.9K±0%$16.6M10.8%
NBIXNeurocrine Biosciences Inc
116.5K±0%$16.5M10.8%
CYTKCytokinetics Inc
228.6K±0%$15.1M9.8%
BHVNBiohaven Ltd.
582.3K±0%$7.8M5.1%
REGNRegeneron Pharmaceuticals, Inc.
4.2K±0%$3.2M2.1%
VORVor Biopharma Inc.
25.4K±0%$484.6K0.3%
BIIBBiogen Inc.
950±0%$214.6K0.1%